|
RLYB | Rallybio Corp |
|
|
RLYB | Rallybio Corp |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.35 |
| Leverage | 6.84% |
| Market Cap | $ 181.4m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -14.3m |
| Margin | -61.47% |
None